Recurrently Deregulated Lncrnas in Hepatocellular Carcinoma
Yang,Lei Chen,Jin Gu,Hanshuo Zhang,Jiapei Yuan,Qiuyu Lian,Guishuai Lv,Siqi Wang,Yang Wu,Yu-Cheng T. Yang,Dongfang Wang,Yang Liu,Jing Tang,Guijuan Luo,Yang Li,Long Hu,Xinbao Sun,Dong Wang,Mingzhou Guo,Qiaoran Xi,Jianzhong Xi,Hongyang Wang,Michael Q. Zhang,Zhi John Lu
DOI: https://doi.org/10.1038/ncomms14421
IF: 16.6
2017-01-01
Nature Communications
Abstract:Hepatocellular carcinoma (HCC) cells often invade the portal venous system and subsequently develop into portal vein tumour thrombosis (PVTT). Long noncoding RNAs (lncRNAs) have been associated with HCC, but a comprehensive analysis of their specific association with HCC metastasis has not been conducted. Here, by analysing 60 clinical samples' RNA-seq data from 20 HCC patients, we have identified and characterized 8,603 candidate lncRNAs. The expression patterns of 917 recurrently deregulated lncRNAs are correlated with clinical data in a TCGA cohort and published liver cancer data. Matched array data from the 60 samples show that copy number variations (CNVs) and alterations in DNA methylation contribute to the observed recurrent deregulation of 235 lncRNAs. Many recurrently deregulated lncRNAs are enriched in co-expressed clusters of genes related to cell adhesion, immune response and metabolic processes. Candidate lncRNAs related to metastasis, such as HAND2-AS1, were further validated using RNAi-based loss-of-function assays. Thus, we provide a valuable resource of functional lncRNAs and biomarkers associated with HCC tumorigenesis and metastasis.